TerrAscend: Analyst Consensus Estimates For Q3 2021

TerrAscend Corp (CSE: TER) announced that they will be reporting their third quarter financials before the markets open on November 16th.

Analysts have a consensus C$17.96 12-month price target on the company, via a total of 8 analysts, with 3 analysts having strong buy ratings, and the other 5 having buy ratings on the company. The street high comes from Stifel-GMP with an C$23 price target, and the lowest target comes from Needham & Company with a C$13.70 price target.

8 analysts have revenue estimates for the third quarter. The mean between all 8 is US$57.82 million; this number has been revised down from US$80.98 million at the start of May. The street high is US$62 million while the lowest sits at US$54.30 million.

7 analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 57.84%, with this number being lower than at the start of May. Street high is 60.70% estimate and the lowest sits at 52%.

Onto EBITDA estimates, there are currently 8 analysts who have third quarter EBITDA estimates. The mean is currently US$19.98 million, with this number has been revised downwards from US$34.01 million at the start of May. Street high sits at US$23.40 million EBITDA and the lowest being a US$15.90 million estimate.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Tariffs Spark New Race for Critical Metals | Rob McEwen

Antimony Resources: The Bald Hill Project

They Laughed at $3,000 Gold, Now We’re Headed for $4,000! | Sean Roosen – Osisko Development Corp.

Recommended

Steadright Begins Preliminary Economic Assessment On TitanBeach Project

Three Miners Trapped Underground At Newmont’s Red Chris Mine

Related News

HEXO: Canaccord Lowers Price Target Following Redecan Transaction Announcement

On May 28th, Hexo Corp (TSX: HEXO) (NYSE: HEXO) announced yet another acquisition. The company...

Tuesday, June 1, 2021, 11:51:00 AM

Sundial: Canaccord Drops Target To $0.50 Following Q1 Results

On Monday, Sundial Growers Inc. (Nasdaq: SNDL) reported its first quarter financial results. The company...

Wednesday, May 18, 2022, 03:44:00 PM

Aphria: Canaccord Anticipates Q2 2021 Revenue Of $156.3 Million

Aphria Inc (TSX: APHA) (NASDAQ: APHA) will be releasing their second-quarter fiscal 2021 financial results...

Tuesday, January 12, 2021, 11:57:00 AM

Small Pharma: Canaccord Initiates Coverage With $1.00 Price Target

Canaccord Genuity recently initiated coverage on Small Pharma Inc (TSXV: DMT), a company that is...

Sunday, June 13, 2021, 01:08:00 PM

Canaccord Raises Mind Medicine’s Price Target To $2.00 Following Financing

This morning, Canaccord Genuity raised its 12-month price target on Mind Medicine (NEO: MMED) from...

Monday, November 2, 2020, 10:45:02 AM